Syndax Pharmaceuticals Inc (SNDX)
Stock-Based Compensation
$49.40M
TTM · Period ending: · USD
SNDX Stock-Based Compensation
Latest reported$49.40Mperiod ending
Latest reported$49.40Mperiod ending
SNDX TTM Stock-Based Comp ($1.42M → $49.40M)
TTM stock-based compensation
High-resolution chart · PNG
SNDX stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 49,403,000 | |
| 49,177,000 | |
| 47,503,000 | |
| 48,546,000 | |
| 48,398,000 | |
| 44,507,000 | |
| 43,026,000 | |
| 39,056,000 | |
| 35,443,000 | |
| 33,612,000 | |
| 30,951,000 | |
| 26,865,000 | |
| 22,906,000 | |
| 18,779,000 | |
| 16,019,000 | |
| 15,707,000 | |
| 14,726,000 | |
| 14,028,000 | |
| 13,317,000 | |
| 11,423,000 | |
| 11,105,000 | |
| 9,995,000 | |
| 9,057,000 | |
| 8,547,000 | |
| 7,034,000 | |
| 6,242,000 | |
| 6,005,000 | |
| 5,952,000 | |
| 6,139,000 | |
| 6,372,000 | |
| 6,201,000 | |
| 6,009,000 | |
| 5,617,000 | |
| 5,494,000 | |
| 5,450,000 | |
| 5,117,000 | |
| 4,564,000 | |
| 3,895,000 | |
| 4,708,000 | |
| 4,931,000 | |
| 5,427,000 | |
| 5,748,000 | |
| 3,882,000 | |
| 3,122,000 | |
| 2,718,000 | |
| 1,982,000 | |
| 2,257,000 | |
| 2,259,000 | |
| 1,553,000 | |
| 1,999,000 | |
| 1,415,000 | |
| 1,003,045 |